Trial · NCT03283085
Results by group34
Each measurement the trial posted, group by group, in the words and numbers it posted.
21 to 34 of 34
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Discernible Changes in Electrocardiogram (ECG) Over Time | UC: Ontamalimab 75 mg | 0 | 0 to 0 | Participants | |
| Number of Participants With Discernible Changes in Electrocardiogram (ECG) Over Time | CD: Ontamalimab 25 mg | 0 | 0 to 0 | Participants | |
| Number of Participants With Discernible Changes in Electrocardiogram (ECG) Over Time | CD: Ontamalimab 25 mg Then 75 mg | 0 | 0 to 0 | Participants | |
| Number of Participants With Discernible Changes in Electrocardiogram (ECG) Over Time | CD: Ontamalimab 75 mg | 0 | 0 to 0 | Participants | |
| Number of Participants With Discernible Changes in Vital Signs Over Time | UC: Ontamalimab 25 mg | 0 | 0 to 0 | Participants | |
| Number of Participants With Discernible Changes in Vital Signs Over Time | UC: Ontamalimab 25 mg Then 75 mg | 0 | 0 to 0 | Participants | |
| Number of Participants With Discernible Changes in Vital Signs Over Time | UC: Ontamalimab 75 mg | 0 | 0 to 0 | Participants | |
| Number of Participants With Discernible Changes in Vital Signs Over Time | CD: Ontamalimab 25 mg | 0 | 0 to 0 | Participants | |
| Number of Participants With Discernible Changes in Vital Signs Over Time | CD: Ontamalimab 25 mg Then 75 mg | 0 | 0 to 0 | Participants | |
| Number of Participants With Discernible Changes in Vital Signs Over Time | CD: Ontamalimab 75 mg | 0 | 0 to 0 | Participants | |
| Number of Participants With Ulcerative Colitis With Treatment Response Over Time | UC: Ontamalimab 25 mg Then 75 mg | 116 | Participants | ||
| Number of Participants With Ulcerative Colitis With Treatment Response Over Time | UC: Ontamalimab 75 mg | 129 | Participants | ||
| Number of Participants With Crohn's Disease With Treatment Response Over Time | CD: Ontamalimab 25 mg Then 75 mg | 6 | Participants | ||
| Number of Participants With Crohn's Disease With Treatment Response Over Time | CD: Ontamalimab 75 mg | 12 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03283085/results?page=2